Literature DB >> 34104136

Problems faced by Researchers and pressure on Impact Factor Journal Editors.

Shaukat Ali Jawaid.   

Abstract

Entities:  

Year:  2021        PMID: 34104136      PMCID: PMC8155420          DOI: 10.12669/pjms.37.3.4296

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


× No keyword cloud information.
It is extremely painful not to accept a couple of manuscripts from researchers for further processing almost daily because of increased submissions and our financial as well as human resource constraints. At present we get almost about two hundred fifty submissions not only from Pakistan but from overseas from many countries in South East Asia and Asia-Pacific in particular every month while we have the facilities to process, manage and publish just about three hundred fifty to four hundred manuscripts every year. It leads to annoyance with authors whose papers are not accepted which is a real dilemma for the Editor. Editor colleagues of the other two Impact Factor medical journals published from Pakistan are faced with a similar situation. While on one hand the authorities claim to promote research culture but at the same time the authors find it extremely difficult to get their studies published in good standard peer reviewed biomedical journals in Pakistan as they are too few just three. IF journals in Pakistan is their first preference to meet requirements of the regulatory bodies like Higher Education Commission which says that all PhD scholars and medical university faculty members should publish their work in Impact Factor Journals. Publication in IF journals overseas is very expensive which many authors cannot afford. Hence, the only way forward is to relax the rules and regulations by the regulatory bodies like HEC or include few more good quality medical journals in its list which even do not enjoy an Impact Factor at present but have applied, are included in the Journal Citation Report (JCR) and are hopeful of getting an IF in the coming years. We on our part has time and again made it clear and highlighted the common reasons for not accepting manuscripts for further processing after initial screening and Editor’s Triage.1 Hence if the authors are careful, read the instructions for authors on our website and make sure that the problems and deficiencies highlighted earlier are avoided, it will minimize trauma to their manuscripts.2 To help authors we from time to time do include some manuscripts with the main objective of educating the authors.3 The situation can improve a lot if medical institutions organize regular training workshops for their faculty members, undergraduate and postgraduate students on Scientific Writing. Secondly each institution must have some facilities whereby the authors are given advice after looking at their manuscripts in pre-submission stage. The Dept. of Medical Education can also be entrusted this responsibility which will not only improve the quality of these manuscripts but also go a long way in reducing the rejection rate. At the same time all the journals editors should also feel it their responsibility to train the authors by facilitating training workshops in collaboration with different medical institutions. In Pakistan, a few distinguished medical editors have been facilitating such workshops all over the country from the platform of Pakistan Association of Medical Editors (PAME) for the last many years but still a lot more needs to be done. In order to know our strength and weaknesses, we started conducting our own publication audit a couple of years ago which is now done annually on regular basis. The last publication audit was done in 2019. 4 A careful analysis for the year 2020 revealed that we received 1,781 manuscripts after initial screening. Of these 389 were published after peer review, thirteen were rejected because of plagiarism, twenty eight were withdrawn by the authors themselves as they wanted quick publication soon after submission and we could not oblige them. Table-I. During the Year under review submissions from Pakistan were 854 and the rest were from overseas. Major submissions from overseas included 352 papers from Turkey, 202 from China, 144 from Saudi Arabia, 40 from Iran, 29 from Indonesia, 24 from Iraq and 14 from Egypt. Table-II. As compared to the previous year 2018 we receipted only 1419 submissions in 2019 since we were not entertaining new submissions for some time. New submissions were again stopped for three months during 2020 due to COVID19 Pandemic as our offices remained closed for some time and we wanted to clear the backlog first. However, despite that new submissions increased in 2020 to 1781 as compared to the previous year. Fig.1.
Table-I

PJMS manuscripts statistics of 2020 at a Glance.

Articles Published389
Articles not accepted for further processing1217
Articles Rejected because of Plagiarism13
Articles Withdrawn by Authors28
Under Process:134
Total submissions1781
Table-II

Country wise submissions during 2020.

CountryTotal
Algeria2
Australia1
Bahrain2
Canada3
China202
Colombia2
Cyprus3
Egypt14
France1
Georgia1
Germany1
India10
Indonesia29
Iran40
Iraq24
Ireland3
Isle of Man1
Italy3
Jordan9
Kazakhstan3
Korea7
Kuwait2
Malaysia9
Nigeria11
Norway3
Oman1
Pakistan854
Palestinian1
Philippines2
Portugal1
Qatar2
Russia2
Saudi Arabia144
Serbia4
South Africa2
Sudan2
Thailand3
Turkey352
UAE2
United Kingdom12
United States of America8
Viet Nam1
Taiwan1
Brazil1

Grand Total1781
Fig.1

Submissions and acceptance Pak J Med Sci (2011-2020).

PJMS manuscripts statistics of 2020 at a Glance. Country wise submissions during 2020. Submissions and acceptance Pak J Med Sci (2011-2020). Further analysis of submissions showed that the number of manuscripts published after peer review increased from 168 to 241 from Pakistan, from 46 to 66 from China, from 32 to 35 from Saudi Arabia. However, their number decreased from Turkey from 60 to 28, and four from eight from Islamic Republic of Iran. Table-III. One of the main reasons being that we encourage the authors from overseas to prefer publication of their research work in their own country’s standard peer reviewed journals in view of the increasing cost of publication charges.
Table-III

Manuscript published by Pak J Med Sci (2010 – 2020).

Country20102011201220132014201520162017201820192020
Algeria11
Australia1111
Bahrain111
Bangladesh4441111
Canada1
Cameroon1
China118348089656654434666
Cyprus1131
Fiji1
Germany1
India2111111
Iran6478637014121110384
Iraq132311231
Ireland1
Japan1
Jordan411
Kenya1
Korea1213257221
Kuwait11
Malaysia19397106112
Nigeria1094411
Norway1
Oman1111
Pakistan5693659193106135163150168241
Palestine2312
Philippines1
Poland24
Romania1131111
Saudi Arabia116161719322321243235
Serbia1111
South Africa3216211
Sudan1
Taiwan223
Thailand2
Turkey3474373860656349726028
UAE4112131
Uganda1
UK2512111112
USA421

Total205307236330301315321308311325389
Manuscript published by Pak J Med Sci (2010 – 2020). As expected majority of the submissions from within the country were again from major cities i.e. 261 from Karachi, 226 from Lahore, 101 from Islamabad, 62 from Peshawar, 43 from Rawalpindi, 24 from Faisalabad, 29 from Hyderabad including Jamshoro and 12 from Bahawalpur. Table-IV. Majority of the articles published during 2020 were also original manuscripts which accounted for 311 followed by Case Reports 13. Special and Brief or short communications accounted for 24, Editorials including Guest Editorials were ten. Table-V. We also published two special supplements during 2020 i.e. ICON 2020 in collaboration with Indus Health Network and to accommodate papers on Covid19 Pandemic, a special supplement which contained thirty three manuscripts was also published. Table-VI.
Table-IV

City wise submissions from Pakistan during 2020.

CityTotal
Abbottabad2
Azad Kashmir2
Bahawalnagar1
Bahawalpur12
Bannu1
Chakdara1
Charsadda2
Dera Ghazi Khan3
Dera Ismail Khan2
Faisalabad24
Gujranwala2
Gujrat6
Haripur2
Hyderabad19
Islamabad101
Jamshoro10
Karachi261
Khairpur3
Kharian1
Lahore226
Larkana2
Mansehra3
Mardan4
Mirpur, Azad Kashmir1
Mirpurkhas1
Multan26
Nawabshah1
Nowshera1
Pakpattan1
Peshawar62
Quetta11
Rahim Yar Khan1
Rawalakot1
Rawalpindi43
Sahiwal1
Sargodha3
Sialkot4
Swat3
Taxila2
Wah Cantt.2

Grand Total854
Table-V

Category Wise Manuscript Published in 2020.

CategoryICON 2020 SupplJan-Feb 2020Mar-Apr 2020May-Jun 2020Jul-Aug 2020Sep-Oct 2020Nov-Dec 2020Covid-19 Suppl 2020Grand Total
Acknowledgement112
Book Review11
Brief Communication2147
Case Reports42121313
Clinical Case Series11114
Continuing Medical Education11
Correspondence21115
Editorial111115
Guest Editorial112127
Guideline11
Letter22
Original Articles1154514445465010311
Publication Audit11
Review Article11147
Short Communication221229
Special Communications11248
Systematic Review112
View Point33

Grand Total2360565153565733389
Table-VI

Country Wise Manuscript Published in 2020.

CountryICON 2020 SupplJan-Feb 2020Mar-Apr 2020May-Jun 2020Jul-Aug 2020Sep-Oct 2020Nov-Dec 2020COVID-19 Suppl. 2020Grand Total
Canada11
China1512481214166
Iran1214
Iraq11
Ireland11
Malaysia112
Nigeria11
Norway11
Oman11
Pakistan2328383233322827241
Romania11
Saudi Arabia548447335
Serbia11
South Africa11
Turkey91545428
United Kingdom112
United States of America11
United Arab Emirates11

Grand Total2360565153565733389
City wise submissions from Pakistan during 2020. Category Wise Manuscript Published in 2020. Country Wise Manuscript Published in 2020. Despite the fact that we always follow an author friendly policy, do our best to help, encourage and guide them but at times we find ourselves helpless when the authors do not bother to carefully read and follow the instructions for authors on the journal website, papers have numerous deficiencies or the English language and Grammar needs extensive improvement. We certainly cannot help re-write these papers which some of these submissions demand, hence the refusal to process them further.5 As a policy we prefer original research in clinical medicine. Manuscripts in certain disciplines like Dentistry, Physical Rehabilitation Medicine and Pharmacy as well as lengthy Reviews, basic sciences, Systemic Reviews and Meta-Analysis have a low priority with us though we do accommodate a few selected ones provided the topic is interesting. KAP studies, routine Survey reports and animal studies are generally not accepted due to our limitations. We feel that there is a great scope of good quality peer reviewed medical journals covering Basic Sciences, Allied Health Sciences including Nursing, Rehabilitation Medicine and Pharmacy. Let us hope that some people will come forward and fill this gap. In order to build the professional capacity of the editors, PAME in collaboration with University of Health Sciences Lahore has started a Certificate Course in Medical Editing.6 So far two batches have completed the training and the third batch will be inducted in May 2021. Hopefully it will also help the new editors thereby improving the quality of their journals.
  5 in total

1.  Are the Editors faced with e-problems performing their duties and responsibilities satisfactorily?

Authors:  Shaukat Ali Jawaid; Masood Jawaid
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

2.  Common reasons for not accepting manuscripts for further processing after editor's triage and initial screening.

Authors:  Shaukat Ali Jawaid; Masood Jawaid
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

3.  Medical Journal Publishing: Continued struggle is essential to Achieve and maintain standards.

Authors:  Shaukat Ali Jawaid
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

4.  Author's failure to read and follow instructions leads to increased trauma to their manuscripts.

Authors:  Shaukat Ali Jawaid; Masood Jawaid
Journal:  Pak J Med Sci       Date:  2018 May-Jun       Impact factor: 1.088

  5 in total
  1 in total

1.  Another landmark achievement by Pakistan Journal of Medical Sciences and the future challenges.

Authors:  Shaukat Ali Jawaid; Masood Jawaid
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.